Grey Matters (Attendee Information)
This site is intended for registered participants of the Grey Matters: Brain and Spine Cancer Symposium.
Welcome! Thank you for joining us.
This symposium is designed to update the target audience on the current multi-disciplinary approach to patients with newly diagnosed or recurrent gliomas. Presentations will be delivered by key thought leaders while allowing the opportunity for participants to be involved in the interactive question/answer sessions.
Symposium Objectives
At the conclusion of this activity, the participant should be better able to:
- Discuss cutting-edge brain and spine cancer research initiatives and resources originating from trials at Nebraska Medicine.
- Summarize the collective responsibility of the multidisciplinary team approach in managing patients with newly diagnosed or recurrent gliomas for optimized patient outcomes while emphasizing shared accountability.
- Explain the importance of obtaining molecular testing in brain tumor patients for more personalized treatment strategies.
- Explain how gliomas can impact patients’ cognitive and physical function.
General Information
Friday, April 19
Read the UNMC CCE Disclosure Declaration Policy
Disclosures
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.
FACULTY
The following faculty members have disclosed relevant financial relationships:
- Michele R. Aizenberg, MD, FAANS, FACS*
Research: Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc.
Research Funding: National Institute of General Medical Sciences - Nicole A. Shonka, MD*
Consultant: GT Medical Technologies, Inc. - Chi (Kevin) Zhang, MD, PhD
Co-Founder: Zcure LLC
Research Grant: AstraZeneca; BioMimetix
The following faculty members have nothing to disclose:
- Sahara J. Cathcart, MD
- Olga Taraschenko, MD, PhD
PLANNING COMMITTEE
The following planning committee members have nothing to disclose:
- Missy Edwards
- Tori Greenlee
- Julie Huglin
- Brenda Ram, CMP, CHCP
*Faculty and planning committee member
The following materials (in PDF) are available for download until May 9, 2024. No part of these materials may be reproduced without prior written permission.
- Central Nervous System Tumor Classification – A Brief Update
Sahara J. Cathcart, MD - Maximizing Surgical Therapy in Brain Tumors
Michele R. Aizenberg, MD, FAANS, FACS - Proton Therapy for Primary Brain Tumors
Chi (Kevin) Zhang, MD, PhD - Adult Gliomas in 2024
Nicole A. Shonka, MD - Seizures in Benign and Malignant Brain Tumors
Olga Taraschenko, MD, PhD - Neuro-Oncology Clinical Trials at Nebraska Medicine
Nicole A. Shonka, MD
Requirements for Successful Completion
In order to receive continuing education credits, you must:
- Check in and attend the live activity.
- Complete the online evaluation via the UNMC MyCCE portal.
- On your dashboard, click Evaluate an Activity.
- Enter Activity Code 59081.
You have until May 9, 2024, to claim credit for this activity. You will need to complete the evaluation and attest to the time you spent participating in the activity. Your certificate will be saved in your UNMC MyCCE account under Certificates & Transcripts.
Need help managing your MyCCE account? Find answers to commonly asked questions about signing in to the portal, completing the online evaluation, retrieving your certificate, and more. Go to Manage MyCCE Account
Symposium Directors
Professor, Department of Neurosurgery, UNMC
Director, Brain and Spine Cancer Center, Nebraska Medicine
Associate Professor, Division of Oncology and Hematology, Department of Internal Medicine, UNMC
Medical Director, Clinic and Infusion Center, Fred & Pamela Buffett Cancer Center
Sponsors
This symposium is co-sponsored by the UNMC Departments of Neurosurgery and Internal Medicine (Division of Oncology and Hematology), and Nebraska Medicine, through the resources of the UNMC Center for Continuing Education.
Questions?
Educational Projects Coordinator
UNMC Center for Continuing Education
